Đánh giá hệ thống và phân tích tổng hợp về kết quả hậu phẫu trong phẫu thuật cắt ruột khẩn cấp và tự chọn ở bệnh nhân mắc bệnh Crohn

Frolkis AD, Dykeman J, Negrón ME, Debruyn J, Jette N, Fiest KM et al (2013) Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology. 145(5):996–1006 Taxonera C, Rodrigo L, Casellas F, Calvet X, Gómez-Camacho F, Ginard D, Castro M, Castro L, Ponce M, Martínez-Montiel P, Ricart E, Gisbert JP, Román ALS, Morales JM, Casado MÁ (2009) Infliximab maintenance therapy is associated with decreases in direct resource use in patients with luminal or fistulizing Crohnʼs disease. J Clin Gastroenterol 43(10):950–956 Ramadas AV, Gunesh S, Thomas GAO, Williams GT, Hawthorne AB (2010) Natural history of Crohn’s disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut. 59(9):1200–1206 Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G et al (2009) Long-term outcome of treatment with infliximab in 614 patients with Crohn’s disease: results from a single-centre cohort. Gut. 58(4):492–500 Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre J-P (2005) Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut. 54(2):237–241 Lazarev M, Ullman T, Schraut WH, Kip KE, Saul M, Regueiro M (2010) Small bowel resection rates in Crohn’s disease and the indication for surgery over time: experience from a large tertiary care center. Inflamm Bowel Dis 16(5):830–835 Tzivanakis A, Singh JC, Guy RJ, Travis SPL, Mortensen NJ, George BD (2012) Influence of risk factors on the safety of ileocolic anastomosis in crohn’s disease surgery. Dis Colon Rectum 55:558–562 Riss S, Schuster I, Papay P, Mittlböck M, Stift A (2013) Repeat intestinal resections increase the risk of recurrence of Crohnʼs disease. Dis Colon Rectum 56(7):881–887 Moftah M, Nazour F, Cunningham M, Cahill RA (2014) Single port laparoscopic surgery for patients with complex and recurrent Crohn’s disease. J Crohn's Colitis 8(9):1055–1061 Freeman HJ (2014) Spontaneous free perforation of the small intestine in adults. World Journal of Gastroenterology 20:9990–9997 El-Hussuna A, Pinkney T, Zmora O, Frasson M, Bhangu A, Battersby N et al (2018) Risk factors for unfavourable postoperative outcome in patients with Crohn’s disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO. Color Dis 20(3):219–227 Lorenz D, Lorenz U, Hagmüller E, Saeger HD (1993) Crohn disease: resection therapy over the course of two decades. Zentralbl Chir 118(3):127–133 discussion 133-4 Yamamoto T, Keighley MRB (1999) Long-term outcome of total colectomy and ileostomy for Crohn disease. Scand J Gastroenterol 34(3):280–286 Serradori T, Germain A, Scherrer ML, Ayav C, Perez M, Romain B et al (2013) The effect of immune therapy on surgical site infection following Crohn’s disease resection. Br J Surg 100(8):1089–1093 Morar PS, Hodgkinson JD, Thalayasingam S, Koysombat K, Purcell M, Hart AL, Warusavitarne J, Faiz O (2015) Determining predictors for intra-abdominal septic complications following ileocolonic resection for Crohn’s disease—considerations in pre-operative and peri-operative optimisation techniques to improve outcome. J Crohn's Colitis 9(6):483–491. https://doi.org/10.1093/ecco-jcc/jjv051 Lee J-S, Kim H-J, Cho H-M, Lee K-M, Kye B-H (2016) The importance of the Crohn’s disease activity index in surgery for small bowel Crohn’s disease. J Visc Surg 153(5):339–345 El-Hussuna A, Hadi S II, El-Hussuna A, Hadi S, Iesalnieks I, Laurberg S, Srensen HT et al (2016) No difference in postoperative outcome after acute surgery whether the patients presented for first time or are known with Crohn’s disease. Int J Surg Open 6:1–4 Panteleimonitis S, Ahmed J, Parker T, Qureshi T, Parvaiz A (2017) Laparoscopic resection for primary and recurrent Crohn’s disease: a case series of over 100 consecutive cases. Int J Surg 47:69–76 Aydinli HH, Aytac E, Remzi FH, Bernstein M, Grucela AL (2018) Factors associated with short-term morbidity in patients undergoing colon resection for Crohn’s disease. J Gastrointest Surg 22(8):1434–1441 Iesalnieks I, Spinelli A, Frasson M, Di Candido F, Scheef B, Horesh N et al (2018) Risk of postoperative morbidity in patients having bowel resection for colonic Crohn’s disease. Tech Coloproctol. 22(12):947–953 Yu CS, Jung SW, Lee JL, Lim SB, Park IJ, Yoon YS, Kim CW, Ynag SK, Ye BD, Park SH, Han M, Kim JC (2019) The influence of preoperative medications on postoperative complications in patients after intestinal surgery for Crohn’s disease. Inflamm Bowel Dis 25(9):1559–1568 Celentano V, O’Leary DP, Caiazzo A, Flashman KG, Sagias F, Conti J, Senapati A, Khan J (2019) Longer small bowel segments are resected in emergency surgery for ileocaecal Crohn’s disease with a higher ileostomy and complication rate. Tech Coloproctol 23(11):1085–1091 Colombel JF, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ (2004) Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99(5):878–883 Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P (2007) Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn’s disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 50(3):331–336 Iesalnieks I, Kilger A, Glaß H, Glass H, Müller-Wille R, Klebl F et al (2008) Intraabdominal septic complications following bowel resection for Crohn’s disease: detrimental influence on long-term outcome. Int J Color Dis 23(12):1167–1174 Kono T, Ashida T, Ebisawa Y, Chisato N, Okamoto K, Katsuno H, Maeda K, Fujiya M, Kohgo Y, Furukawa H (2011) A new antimesenteric functional end-to-end handsewn anastomosis: surgical prevention of anastomotic recurrence in Crohn’s disease. Dis Colon Rectum 54(5):586–592 Riss S, Bittermann C, Schwameis K, Kristo I, Mittlböck M, Herbst F, Stift A (2012) Determinants for postoperative complications after laparoscopic intestinal resection for Crohn’s disease. Surg Endosc 26(4):933–938 Shental O, Tulchinsky H, Greenberg R, Klausner JM, Avital S (2012) Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for crohn’s disease. Dis Colon Rectum 55(11):1125–1130 El-Hussuna A, Andersen J, Bisgaard T, Jess P, Henriksen M, Oehlenschlager J et al (2012) Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn’s disease. Scand J Gastroenterol 47(6):662–668 Kanazawa A, Yamana T, Okamoto K, Sahara R (2012) Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn’s disease. Dis Colon Rectum 55(9):957–962 Fumery M, Seksik P, Auzolle C, Munoz-Bongrand N, Gornet JM, Boschetti G, Cotte E, Buisson A, Dubois A, Pariente B, Zerbib P, Chafai N, Stefanescu C, Panis Y, Marteau P, Pautrat K, Sabbagh C, Filippi J, Chevrier M, Houze P, Jouven X, Treton X, Allez M; REMIND study group investigators (2017) Postoperative complications after Ileocecal resection in Crohn’s disease: a prospective study from the REMIND Group. Am J Gastroenterol 112(2):337–345. https://doi.org/10.1038/ajg.2016.541 Brouquet A, Maggiori L, Zerbib P, Lefevre JH, Denost Q, Germain A et al (2016) Anti-TNF therapy is associated with an increased risk of postoperative morbidity after surgery for ileocolonic Crohn disease: results of a prospective nationwide cohort. Ann Surg 267(2):221–228 Yamamoto T, Keighley MR (1999) Factors affecting the incidence of postoperative septic complications and recurrence after strictureplasty for jejunoileal Crohn’s disease. Am J Surg 178(3):240–245. https://doi.org/10.1016/s0002-9610(99)00165-8 Singh S, Al-darmaki A, Frolkis AD, Seow CH, Leung Y, Novak KL et al (2015) Postoperative mortality among patients with inflammatory bowel diseases: a systematic review and meta-analysis of population-based studies. Gastroenterology. 149(4):928–937 Law CCY, Sasidharan S, Rodrigues R, Nguyen DD, Sauk J, Garber J et al (2016) Impact of specialized inpatient IBD care on outcomes of IBD hospitalizations : a cohort study. Inflamm Bowel Dis 22(9):2149–2157 de Groof EJ, Carbonnel F, Buskens CJ, Bemelman WA (2014) Abdominal abscess in Crohn’s disease: multidisciplinary management. Dig Dis 32(s1):103–109 Bennett JL, Ha CY, Efron JE, Gearhart SL, Lazarev MG, Wick EC (2015) Optimizing perioperative Crohn’s disease management: role of coordinated medical and surgical care. World J Gastroenterol 21(4):1182–1188 El-Hussuna A, Iesalnieks I, Horesh N, Hadi S, Dreznik Y, Zmora O (2017) The effect of pre-operative optimization on post-operative outcome in Crohn’s disease resections. Int J Color Dis 32(1):49–56 Zangenberg MS, Horesh N, Kopylov U, El-Hussuna A (2017) Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review. International Journal of Colorectal Disease 32:1663–1676 Buskens CJ, Bemelman WA (2019) The surgeon and inflammatory bowel disease. British Journal of Surgery 106:1118–1119 Ponsioen CY, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Bossuyt PMM, Hart A, Warusavitarne J, Buskens CJ, van Bodegraven AA, Brink MA, Consten ECJ, van Wagensveld BA, Rijk MCM, Crolla RMPH, Noomen CG, Houdijk APJ, Mallant RC, Boom M, Marsman WA, Stockmann HB, Mol B, de Groof AJ, Stokkers PC, D'Haens GR, Bemelman WA, Bruin K, Maring J, van Ditzhuijsen T, Prins H, van den Brande J, Kingma P, van Geloven A, de Boer N, van der Peet D, Jansen J, Gerhards M, van der Woude J, Schouten R, Oldenburg B, van Hillegersberg R, West R, Mannaerts G, Spanier M, Spillenaar Bilgen EJ, Lieverse R, van der Zaag E, Depla A, van de Laar A, Bolwerk C, Brouwer H, Mahmmod N, Hazebroek E, Vecht J, Pierik R, Dijkstra G, Hofker S, Uiterwaal T, Eijsbouts Q, Oostenbrug L, Sosef M, Cahen D, van der Werff S, Marinelli A, Peters J, Cense H, Talstra N, Morar P (2017) Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn’s disease: a randomised controlled, open-label, multicentre trial. Lancet Gastroenterol Hepatol 2(11):785–792 Haider AH, Obirieze A, Velopulos CG, Richard P, Latif A, Scott VK, Zogg CK, Haut ER, Efron DT, Cornwell EE III, MacKenzie EJ, Gaskin DJ (2015) Incremental cost of emergency versus elective surgery. Ann Surg 262(2):260–266 El-Hussuna A, Myrelid P, Holubar SD, Kotze PG, Mackenzie G, Pellino G et al (2019) Biological treatment and the potential risk of adverse postoperative outcome in patients with inflammatory bowel disease: an open-source expert panel review of the current literature and future perspectives. Crohn’s Colitis 360 1(3):1–14